Greenwood Capital Associates’s Boston Scientific BSX Stock Holding History

Greenwood Capital Associates’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.35M	Buy	+78,520	New	+$4.26M	0.33%	90
2017 Q4	–	Sell	-91,579	Closed	-$2.67M	–	218
2017 Q3	$2.67M	Buy	91,579 +38,249	+72%	+$1.06M	0.66%	70
2017 Q2	$1.48M	Buy	53,330 +564	+1%	+$15K	0.38%	80
2017 Q1	$1.31M	Buy	52,766 +5,548	+12%	+$135K	0.34%	88
2016 Q4	$1.02M	Sell	47,218 -1,620	-3%	-$35.3K	0.29%	86
2016 Q3	$1.16M	Buy	+48,838	New	+$1.17M	0.35%	79
2016 Q2	–	Sell	-13,128	Closed	-$247K	–	175
2016 Q1	$247K	Buy	13,128 +549	+4%	+$9.64K	0.08%	144
2015 Q4	$232K	Buy	12,579 +225	+2%	+$4.03K	0.07%	142
2015 Q3	$203K	Buy	12,354 +40	+0.3%	+$684	0.07%	148
2015 Q2	$217K	Buy	12,314 +90	+0.7%	+$1.61K	0.07%	144
2015 Q1	$216K	Buy	+12,224	New	+$193K	0.06%	144

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Greenwood Capital Associates's BSX Position: Q2 2026 in Review

Greenwood Capital Associates opened a new position in Boston Scientific (BSX) in Q2 2026: 78,520 shares worth $3.35M. The stake represents 0.33% of the portfolio and ranks #90 among its holdings. This is a return to the name: Greenwood Capital Associates previously reported a position in BSX as recently as Q3 2017.

Greenwood Capital Associates first reported a position in BSX in Q1 2015 and has held it in 11 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Greenwood Capital Associates held 78,520 shares of Boston Scientific worth $3.35M as of Q2 2026.
Boston Scientific was a new Greenwood Capital Associates position in Q2 2026.
Boston Scientific made up 0.33% of Greenwood Capital Associates's portfolio in Q2 2026, its #90 holding.
Greenwood Capital Associates first reported a position in Boston Scientific in Q1 2015 and has held it in 11 quarters since.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Greenwood Capital Associates's 13F filing for Q2 2026, filed 28 Jul 2026.